Ru Li

Ru Li

47 year
Health Technology
Consumer Services

Profile

Ru Li currently works at Shanghai Shyndec Pharmaceutical Co., Ltd., as Director from 2022, China National Pharmaceutical Group Co., Ltd., as Deputy Director & Director-Risk & Operation from 2012, Sinopharm Common Wealth Co. Ltd., as Director, Chongqing Taiji Industry (Group) Co., Ltd., as Member-Supervisory Board from 2021, and China National of Traditional & Herbal Medicine Co., Ltd., as Member-Supervisory Board.
Ms. Li also formerly worked at China Traditional Chinese Medicine Holdings Co. Ltd., as Non-Executive Director from 2019 to 2025, Takeda AS, as Market Manager from 2010 to 2012, and China National Medicines Co., Ltd., as Manager-Product, Regional & Divisional Sales from 2001 to 2010.
Ms. Li received her undergraduate degree in 2001 from Shenyang Pharmaceutical University.

Ru Li active positions

CompaniesPositionStart
CHONGQING TAIJI INDUSTRY(GROUP) CO.,LTD Director/Board Member 19/05/2021
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Director/Board Member 28/11/2022
Director/Board Member -
Corporate Officer/Principal 01/01/2012

Former positions of Ru Li

CompaniesPositionEnd
CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO. LIMITED Director/Board Member 15/01/2025
Sales & Marketing 01/01/2012
CHINA NATIONAL MEDICINES CORPORATION LTD. Corporate Officer/Principal 01/01/2010
See the detail of Ru Li's experience

Training of Ru Li

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

42

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services